Reviews
Average rating: 2.5/5
Other Medical Provider ( 2 )
-
5
-
4
-
3
-
2
-
1
Average rating: 5/5
Physician ( 1 )
-
5
-
4
-
3
-
2
-
1
Average rating: 3.33/5
Total Reviews: 3
-
5
-
4
-
3
-
2
-
1
Lysteda is a common first-line option for managing von Willebrand disease, particularly in cases linked to low VWF levels, such as those with type O blood. It offers an effective, non-intravenous alternative to Humate-P.
0
Tranexamic acid is an antifibrinolytic used in von Willebrand disease to reduce mucosal bleeding by preventing clot breakdown. It is often used with desmopressin or vWF replacement and is available as oral tablets, solution, IV, or topical rinse. It’s generally safe but should be used cautiously in patients with kidney disease or clotting risk.
0
0